SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 132 filers reported holding SCICLONE PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $1,056,000 | +1.4% | 94,464 | -0.1% | 0.00% | 0.0% |
| Q2 2017 | $1,041,000 | +28.7% | 94,599 | +14.4% | 0.00% | 0.0% |
| Q1 2017 | $809,000 | -9.6% | 82,667 | -0.3% | 0.00% | 0.0% |
| Q4 2016 | $895,000 | +102.9% | 82,891 | +91.4% | 0.00% | – |
| Q3 2016 | $441,000 | +293.8% | 43,314 | +400.2% | 0.00% | – |
| Q2 2016 | $112,000 | +23.1% | 8,660 | 0.0% | 0.00% | – |
| Q1 2016 | $91,000 | +9.6% | 8,660 | -4.9% | 0.00% | – |
| Q4 2015 | $83,000 | +31.7% | 9,102 | 0.0% | 0.00% | – |
| Q3 2015 | $63,000 | -26.7% | 9,102 | 0.0% | 0.00% | – |
| Q2 2015 | $86,000 | +7.5% | 9,102 | 0.0% | 0.00% | – |
| Q1 2015 | $80,000 | 0.0% | 9,102 | 0.0% | 0.00% | – |
| Q4 2014 | $80,000 | +19.4% | 9,102 | -6.3% | 0.00% | – |
| Q3 2014 | $67,000 | – | 9,715 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 1,663,281 | $16,300,000 | 9.19% |
| Nantahala Capital Management | 1,891,328 | $18,535,000 | 2.06% |
| Nine Chapters Capital Management LLC | 40,700 | $399,000 | 0.54% |
| MENTA CAPITAL LLC | 396,336 | $3,884,000 | 0.38% |
| Sapphire Star Partners LP | 30,439 | $298,000 | 0.34% |
| TFS CAPITAL LLC | 95,432 | $935,000 | 0.30% |
| Ativo Capital Management LLC | 123,428 | $1,210,000 | 0.30% |
| GLG Partners LP | 363,188 | $3,559,000 | 0.17% |
| GSA CAPITAL PARTNERS LLP | 240,013 | $2,352,000 | 0.13% |
| Bowling Portfolio Management LLC | 68,473 | $671,000 | 0.11% |